Europe 1 with AFP 3:45 p.m., November 17, 2021
The pharmaceutical giant Novavax has applied for authorization of its vaccine against Covid-19 in the European Union, the European Medicines Agency (EMA) announced on Tuesday, specifying that an opinion could be issued in "a few weeks ".
The American pharmaceutical company Novavax has submitted an application for authorization of its vaccine against Covid-19 in the European Union, the European Medicines Agency (EMA) announced on Tuesday, specifying that an opinion could be issued in "a few weeks ".
"The EMA has started to assess an application for a conditional marketing authorization for Novavax's anti-Covid vaccine" said the European regulator in a press release, specifying that "a notice on the marketing authorization on the market could be issued in a few weeks ".
More information to come ...